Advanced search
Publication Cover
Postgraduate Medicine Volume 132, 2020 - Issue 2
Submit an article Journal homepage
4,203
Views
7
CrossRef citations to date
0
Altmetric
Clinical Features - Review

Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β2-agonist bronchodilators

Neil S. Skolnika Family/Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Jenkintown, PA, USACorrespondence[email protected]
View further author information
,
Trang Susan Nguyenb Roseman University of Health Sciences, College of Pharmacy, Henderson, NV, USAView further author information
,
Aarisha Shresthaa Family/Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Jenkintown, PA, USAView further author information
,
Riju Rayc US Medical Affairs, GSK, Research Triangle Park, NC, USAView further author information
,
Thomas C. Corbridgec US Medical Affairs, GSK, Research Triangle Park, NC, USAView further author information
&
Stephen A. Bruntond Primary Care Respiratory Group, Palm Springs, CA, USAView further author information
Pages 198-205 | Received 19 Sep 2019, Accepted 06 Dec 2019, Published online: 03 Jan 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Stephen A. Brunton & D. Kyle Hogarth. (2023) Overuse of long-acting β2-agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns. Postgraduate Medicine 135:8, pages 784-802.
Read now
Juan Antonio Trigueros, Noé Garin, Adolfo Baloira, Susana Aceituno, Ana Calvo, Miriam Prades, Carolina Touron, Anisia Martínez & Covadonga Torres. (2022) Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2905-2917.
Read now
Robert M Burkes & Ralph J Panos. (2020) Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease. Journal of Experimental Pharmacology 12, pages 589-602.
Read now

Articles from other publishers (4)

Allan Klitgaard, Rikke Ibsen, Jesper Lykkegaard, Ole Hilberg & Anders Løkke. (2024) National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018. Biomedicines 12:2, pages 372.
Crossref
Victoria Jessamine, Samir Mehndiratta, Gabriele De Rubis, Keshav Raj Paudel, Saritha Shetty, Divya Suares, Dinesh Kumar Chellappan, Brian G. Oliver, Phillip M. Hansbro & Kamal Dua. (2024) The application of nanoparticles as advanced drug delivery systems in Attenuating COPD. Heliyon 10:3, pages e25393.
Crossref
Ye Jin Lee, Chin Kook Rhee, Yong Il Hwang, Kwang Ha Yoo, So Eun Lee, Doik Lee, Yong Bum Park & Youlim Kim. (2021) Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study. Journal of Personalized Medicine 11:12, pages 1325.
Crossref
A. I. Sinopalnikov. (2021) Pharmacotherapeutic strategy for COPD patients: focus on dual bronchodilators. Meditsinskiy sovet = Medical Council:16, pages 38-44.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.